We know from human [39, 47] and animal studies [33, 44, 48] that TG2 is hugely elevated in CKD, predominantly in the tubular epithelium—likely as part of its role as an early wound response enzyme to stabilize the ECM and activate TGFβ1 to drive cell proliferation. This evidence concerns the gene TGFB1 and chronic kidney disease.